Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 245-250

  Jansen, Léon ^a   Claij, Nanna ^a   Dekker, Marleen ^a   Van Klink, Yvonne ^a   Van Der Valk, Martin ^a   Van 't Wout, Karin ^a   Te Riele, Hein ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cancer predisposition; HNPCC; Methylation damage; Mismatch repair; Mouse models

Indexed keywords

6 O BENZYLGUANINE; DIMETHYLHYDRAZINE; ETHYLNITROSOUREA; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA;

ANIMAL CELL; ANIMAL MODEL; CANCER SUSCEPTIBILITY; CELL LINE; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; GENOTOXICITY; HEMIZYGOSITY; IN VITRO STUDY; LYMPHOMA; MODEL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE PAIR MISMATCH; CELLS, CULTURED; DNA REPAIR; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; LYMPHOMA; MICE; MUTAGENS; MUTS HOMOLOG 2 PROTEIN; PROTO-ONCOGENE PROTEINS;

EID: 0034653959     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00277-5     Document Type: Conference Paper

References (25)

1. Aaltonen L.A., Peltomäki P., Leach F.S., Sistonen P., Pylkkanan L., Mecklin J.P., Jarvinen H., Powell S.M., Jen J., Hamilton S.R. et al. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
2. Akiyama Y., Sato H., Yamada T., Nagasaki H., Tsuchiya A., Abe R., Yuasa Y. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 57:1997;3920-3923.
3. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N., Flavell R.A., Liskay R.M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
4. Baker S.M., Plug A.W., Prolla T.A., Bronner C.E., Harris A.C., Yao X., Christie D.M., Monel L.C., Arnheim N., Bradley A., Ashley T., Liskay R.M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13:1996;336-342.
5. Bronner C.E., Baker S.M., Morrison P.T., Warren G., Smith L.G., Lescoe M.K., Kane M., Earabino C., Lipford J., Lindblom A. et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 368:1994;258-261.
6. De Wind N., Dekker M., Berns A., Radman M., Te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82:1995;321-330.
7. De Wind N., Dekker M., Van Rossum A., Van der Valk M., Te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res. 58:1998;248-255.
8. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA. 87:1990;5368-5372.
9. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA. 93:1996;6443-6447.
10. Edelmann W., Cohen P.E., Kane M., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., . Pollard J.W., Kolodner R.D., Kucherlapati R. Meiotic pachytene arrest in MLH1-deficient mice. Cell. 85:1996;1125-1134.
11. Fishel R., Lescoe M.K., Rao M.R.S., Copeland N.G., Jenkins N.A., Garber J., Kane M., Kolodner R. The human mutator homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell. 75:1993;1027-1038.
12. Griffin S., Branch P., Xu Y.-Z., Karran P. DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry. 33:1994;4787-4793.
13. Ionov J., Peinado P.A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
14. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1996;1433-1442.
15. 6-Methylguanine-DNA adducts protects transgenic mice from N-Methylnitrosourea-induced thymic lymphomas. Cancer Res. 54:1994;4648-4652.
16. Loeb L.A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 54:1994;5059-5063.
17. Lynch H.T., Smyrk T., Lynch J., Fitzgibbons R. Jr, Lanspa S., McGinn T. Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer. Eur. J. Cancer. 31A:1995;1039-1046.
18. Modrich P. Mechanisms and biological effects of mismatch repair. Annu. Rev. Genet. 25:1991;229-253.
19. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., Igari T., Koike M., Chiba M., Mori T. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genet. 17:1997;271-272.
20. Nicolaides N.C., Papadopoulos N., Liu B., Wei Y.F., Carter K.C., Ruben S.M., Rosen C.A., Haseltine W.A., Fleischman R.D., Fraser C.M. et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371:1994;75-80.
21. 6-methylguanine residues. Biochemistry. 33:1994;9169-9177.
22. Reitmair A.H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H.W., Wakeham A., Liu B., Thomason A., Griesser H., Gallinger S., Ballhausen W.G., Fishel R., Mak T.W. MSH2-deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet. 11:1995;64-70.
23. Thibodeau S., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816-819.
24. Toft N.J., Winton D.J., Kelly J., Howard L.A., Te Riele H., Arends M.J., Wyllie A.H., Margison G.P., Clarke A.R. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. USA. 96:1999;3911-3915.
25. Zhu W., Yamasaki H., Mironov N. Frequency of HPRT gene mutations induced by N-methyl-N′-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines. Mutat. Res. 398:1998;93-99.